Skip to main content
. 2018 Nov 14;162:171–177. doi: 10.1016/j.antiviral.2018.11.004

Fig. 3.

Fig. 3

IMVAMUNE vaccine study. (A) Prospective participant reviewing study consent documents with local study coordinator. (B) Serum collection prior to vaccination. (C) Vaccination of the first participant in the study.